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A B S T R A C T
Bioaerosols have been associated with adverse respiratory-related health effects and are emitted in elevated
concentrations from composting facilities. We used modelled Aspergillus fumigatus concentrations, a good in-
dicator for bioaerosol emissions, to assess associations with respiratory-related hospital admissions. Mean daily
Aspergillus fumigatus concentrations were estimated for each composting site for first full year of permit issue
from 2005 onwards to 2014 for Census Output Areas (COAs) within 4 km of 76 composting facilities in England,
as previously described (Williams et al., 2019). We fitted a hierarchical generalized mixed model to examine the
risk of hospital admission with a primary diagnosis of (i) any respiratory condition, (ii) respiratory infections,
(iii) asthma, (iv) COPD, (v) diseases due to organic dust, and (vi) Cystic Fibrosis, in relation to quartiles of
Aspergillus fumigatus concentrations. Models included a random intercept for each COA to account for over-
dispersion, nested within composting facility, on which a random intercept was fitted to account for clustering of
the data, with adjustments for age, sex, ethnicity, deprivation, tobacco sales (smoking proxy) and traffic load (as
a proxy for traffic-related air pollution). We included 249,748 respiratory-related and 3163 Cystic Fibrosis
hospital admissions in 9606 COAs with a population-weighted centroid within 4 km of the 76 included com-
posting facilities. After adjustment for confounders, no statistically significant effect was observed for any re-
spiratory-related (Relative Risk (RR) = 0.99; 95% Confidence Interval (CI) 0.96–1.01) or for Cystic Fibrosis
(RR = 1.01; 95% CI 0.56–1.83) hospital admissions for COAs in the highest quartile of exposure. Similar results
were observed across all respiratory disease sub-groups. This study does not provide evidence for increased risks
of respiratory-related hospitalisations for those living near composting facilities. However, given the limitations
in the dispersion modelling, risks cannot be completely ruled out. Hospital admissions represent severe re-
spiratory episodes, so further study would be needed to investigate whether bioaerosols emitted from com-
posting facilities have impacts on less severe episodes or respiratory symptoms.
1. Introduction
Biological air pollution (bioaerosols) is a complex mixture of
airborne fungal, bacterial and pollen species, cellular constituents, and
particulate matter which can be viable or non-viable (Douwes et al.,
2003; Pearson et al., 2015). Bioaerosols are ubiquitous in the
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environment but are emitted in elevated quantities (up to nine orders of
magnitude above background) during large scale composting, particu-
larly when the compost is handled or agitated (e.g. shredded, turned or
screened) (Pearson et al., 2015; Robertson et al., 2019; Taha et al.,
2006; Wery, 2014). The number of large scale composting facilities
(that require a permit to operate) in England has increased by over
150% in the last ten years (Environment Agency, 2018) as a result of
European Union (EU) directives to divert waste from landfill (EU
Landfill directive 1999/31/EC) (The Council of the European Union,
1999).
Bioaerosols emitted from composting facilities are typically less
than 3 μm in diameter (Feeney et al., 2018; Gales et al., 2015;
Gutarowska et al., 2015; O'Connor et al., 2015; Pahari et al., 2016;
Tamer Vestlund et al., 2014) and are, therefore, respirable (Byeon et al.,
2008; Chiang et al., 2003; Wery, 2014). A well-described and common
component of bioaerosols is Aspergillus fumigatus, a pathogenic fungus
that can trigger inflammatory, immunological, and allergic responses
when inhaled (Lacey and Dutkiewicz, 1994; Pearson et al., 2015; Swan
et al., 2003; Sykes et al., 2007; Wery, 2014). Its abundance and pa-
thogenic characteristics makes it a good indicator for bioaerosol emis-
sions in epidemiological studies (see Appendix A for a more detailed
justification).
To date, there have been a limited number of studies examining the
health effects of bioaerosols from composting facilities in community
settings, as highlighted in a systematic review (Pearson et al., 2015),
and subsequent update (Robertson et al., 2019). These studies have
mostly relied on self-reported health symptoms, and/or proximity in-
dicators as a proxy measure for estimating bioaerosol exposure, pro-
viding mixed results regarding the health effects of bioaerosol emis-
sions. Douglas et al. (2016) conducted a national small area ecological
study, which examined risk of respiratory-related hospital admission in
relation to distance from composting facilities in England between 2008
and 2010. The authors did not find clear evidence for an increased risk
of respiratory-related hospital admission in communities living beyond
250 m of facilities yet did find a small non-statistically significant
(p = 0.054) association with total respiratory admissions when using
distance as a continuous proxy measure for exposure. Distance is a
common, yet rather simple, exposure proxy used in epidemiological
studies when more sophisticated measures are not available. However,
it ignores the influence of other factors in the dispersion patterns and
may lead to exposure misclassification (Hodgson et al., 2007). In this
case, the dispersion of bioaerosols in the nearby areas is likely to be
affected by, albeit not limited to, emission rates at each composting
facility, wind direction and ambient temperature. Therefore, epide-
miological studies would benefit from more comprehensive estimates of
bioaerosol exposure, using more sophisticated tools such as dispersion
models. Recently (Williams et al., 2019), developed the first application
of a dispersion model, Atmospheric Dispersion Modelling System
(ADMS), to estimate Aspergillus fumigatus concentrations from large
scale composting facilities on a national scale for use in epidemiological
studies. This provides an improved exposure measure as it accounts for
wind direction, ambient temperature and composting facility char-
acteristics, among other factors relevant to bioaerosol dispersion.
The purpose of this epidemiological study was to, for the first time,
apply these national dispersion model estimates of Aspergillus fumigatus
concentrations from composting facilities in an epidemiological study.
The dispersion model estimates provide a more sophisticated method of
assessing community exposure to Aspergillus fumigatus emitted from
composting facilities, improving upon previous studies that have relied
on proximity proxies, e.g. Douglas et al. (2016), that do not take ac-
count of wind direction and other factors and therefore resulting in
exposure misclassification. Moreover, instead of relying upon subjective
health outcome data collected from questionnaires as per previous
studies, this epidemiological study utilises objectively collected health
data, reducing recall bias.
Therefore, the aim of this study was to investigate, on a national
scale, whether estimated concentrations of Aspergillus fumigatus emitted
from large scale composting facilities are associated with respiratory-
related hospital admissions, in England, between 2005 and 2014.
2. Materials and methods
2.1. Composting facility selection
Data on composting facilities were obtained from the Environment
Agency (EA) and contained information on all composting facilities that
had a valid permit to operate at the end of 2014 (n = 313, Appendix B
Fig. B1). A facility requires a permit to operate if they store or
treat> 60 tonnes of compost at any one time (GOV.UK, 2014). The
data contained detailed information of each facility, including the date
when the permit was awarded, composting activity type (e.g. open
windrow, in-vessel, etc.) and the facility address. For each composting
facility, the date of the permit was taken as the operational starting
date. Facility addresses were used to locate composting facilities and
delimit the perimeter of the outdoor composting activity component
using Google Earth Pro, as previously described (Williams et al., 2019).
Duplicated composting facilities (n = 22) or those with no outdoor
component (n = 36) or lacking geographical information (n = 38)
were excluded. Of those with an outdoor component, only fully open
windrow facilities were considered (n = 173), as emissions are com-
pletely uncontained and therefore, assumed to have the most impact on
the surrounding community. We included 76 composting facilities in
the main analysis (Fig. 1) due to further criteria applied because of the
characteristics and format of the exposure data (see 2.3. Exposure
Data).
2.2. Study population
All Census Output Areas (COAs) (average of 300 inhabitants) with a
population-weighted centroid (obtained from Office of National
Statistics (ONS) (ONS, 2019)) within 4 km of a composting facility were
included, to ensure that areas with background levels of bioaerosols
were included as a control, based on previous findings (Douglas et al.,
2016; Williams et al., 2019). Population weighted centroids, as opposed
to geometric centroids, were used as these account for population dis-
tribution within the COA and thus, better capture population exposure.
COAs that were within 4 km of multiple composting facilities
(n = 4331) were assigned to the nearest one.
Abbreviations
AIC Akaike information criterion
CI Confidence Interval
COA Census Output Area
COPD Chronic Obstructive Pulmonary Disease
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GP General Practitioner
HES Hospital Episode Statistics
ICD International Classifications of Diseases
NHS National Health Service
ONS Office for National Statistics
PHE Public Health England
PM Particulate Matter
RR Relative Risk
SAHSU Small Area Health Statistics Unit
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2.3. Exposure data
For this epidemiological study, we used the output of a novel ap-
plication of a dispersion model to estimate Aspergillus fumigatus con-
centrations from large scale composting facilities on a national scale
developed by (Williams et al., 2019). In brief, the model uses ADMS, a
well-validated Gaussian-based atmospheric dispersion model (CERC,
2018) to predict daily ground-level concentrations of Aspergillus fumi-
gatus at residential postcode centroids (average 12 households) within
4 km of composting facilities operating between 2005 and 2014. The
dispersion model accounted for variation in meteorological conditions,
including ambient temperature, and reflected seasonal changes in As-
pergillus fumigatus emissions. Although it was not possible to fully
assess the model performance using existing measured bioaerosol data
Fig. 1. Locations of the permitted open windrow composting facilities included in the study (coloured circles) and meteorological stations assigned to each com-
posting facility (coloured triangles). Major cities are indicated (black circles).
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(which was not fit for purpose), we did base model inputs on the best
available data, including results from a recent model validation study
(Douglas et al., 2017), as fully described and discussed in Williams et al.
(2019). Postcodes within 4 km of more than one composting facility
were modelled considering the combined emission of all the com-
posting facilities involved.
ADMS is designed to simulate dispersion of more standard air
pollutants (e.g. particulate matter (PM), nitrogen oxides (NOx), sulphur
dioxide (SO2), etc.). Previous evidence shows that Aspergillus fumigatus
has a diameter of typically< 3 μm (Feeney et al., 2018; Gales et al.,
2015; Gutarowska et al., 2015; O'Connor et al., 2015; Pahari et al.,
2016; Tamer Vestlund et al., 2014) (Appendix A). Therefore, we mod-
elled PM with a diameter less than 2.5 μm (PM2.5) as a proxy for As-
pergillus fumigatus emissions, which is considered a relevant indicator of
Fig. 2. Data cleaning flowchart of the hospital admissions data used in the study analysis. The exclusions are shaded in light grey. The outcomes investigated, and for
which results are presented, are shaded in black.
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bioaerosols (Lacey and Dutkiewicz, 1994; Pankhurst et al., 2011;
Pearson et al., 2015; Swan et al., 2003; Sykes et al., 2007; Wery, 2014;
Williams et al. 2013, 2019), as discussed in Appendix A. Model input
parameters relevant to Aspergillus fumigatus dispersion were included in
the model (e.g. exit velocity and temperature) as well as meteorological
information (e.g. ambient temperature, wind direction and speed).
Composting facilities were assigned to a meteorological station based
on their spatial proximity and climate representativeness of the area
(Fig. 1). More information on the dispersion model specifications can be
found in Williams et al. (2019).
2.3.1. Harmonising exposure data
Exposure, health, population and confounder data were available at
different geographical levels and consequently harmonised to COAs
(using 2011 census boundaries), the highest spatial unit at which all
data were available. For the exposure data, each COA was assigned the
modelled estimates from the nearest composting facility. Composting
facilities with COAs within 4 km of other composing facilities were
excluded from the main analyses (Appendix B, Fig. B1.) to avoid
overestimating the exposure (as the model accounted for the combined
emission, rather than the one from the nearest composting facility
only).
Daily average postcode-level Aspergillus fumigatus concentrations
were spatially aggregated to COAs using a postcode-weighted approach
(Appendix C). As dispersion modelling was conducted at postcode level,
some COAs that had a population-weighted centroid within 4 km of a
composting facility did not have Aspergillus fumigatus concentrations
modelled for all of the postcodes (as they would be outside the 4 km
area) (n = 979). Only COAs with all postcodes modelled were included
in the main analysis.
Daily Aspergillus fumigatus concentrations were temporally ag-
gregated to obtain a mean daily concentration for each COA over the
entire operational period covering the nearest full year from 2005 on-
wards that the composting facility was awarded permission to the end
of the study period in 2014 (details in Appendix C). These were cate-
gorised into quartiles relative to each composting facility to highlight
the spatial gradient of bioaerosols concentrations at each individual
facility (so the upper quartile for facility A may be similar to the lower
quartile for facility B, for example). This was done to manage the high
variability in modelled concentrations observed and to account for
baseline exposure differences at facility level, as the exact emission
rates were not available. This allowed us to assess whether, given a
composting facility, there is a different risk of respiratory-related hos-
pitalisation for COAs that have higher versus lower concentrations of
Aspergillus fumigatus, without looking at the absolute concentrations.
Thirty-one of the 107 composting facilities were excluded as there
were< 12 COAs within 4 km of the facility, a threshold set to mean-
ingfully categorize the exposure into quartiles) (Appendix B, Fig. B1.).
2.4. Health data
Data on hospital admissions between 2005 and 2014 for the selected
COAs were obtained from the Hospital Episode Statistics (HES) national
dataset held by the UK Small Area Health Statistics Unit (SAHSU),
provided by National Health Service (NHS) Digital. The HES inpatient
dataset is a comprehensive administrative dataset that records all
hospital admissions at NHS and NHS–funded hospitals and facilities in
England. On admission to hospital, a period of care is opened, termed
‘episode’. One unique admission may be given several episodes if the
patient was attended by multiple consultants, with the first episode of
care relating to the primary cause of hospitalisation. Each episode
contains a primary diagnosis field and up to 19 secondary diagnosis
fields. Only the primary diagnosis of the first episode was considered
for each admission. Diagnostic codes included in this study, as defined
by the International Classification of Disease, 10th edition (ICD-10)
(WHO, 2010), were as follows: (i) all respiratory-related diseases (ICD-
10: J00-99), (ii) respiratory infections (ICD10: J00-22), (iii) asthma
(ICD10: J45-46), and (iv) chronic obstructive pulmonary disease
(COPD) (ICD10: J40- 44). We also analysed hospital admissions of
Cystic Fibrosis (ICD10: E84) as patients with this condition are sus-
ceptible to infections caused by Aspergillus fumigatus exposure. For ex-
ample, allergic bronchopulmonary aspergillosis occurs in approxi-
mately 10% of Cystic Fibrosis patients (Burgel et al., 2016; Garczewska
et al., 2016). Disease due to organic dust (ICD10: J66-67) were also
investigated, yet results are not presented due to too few cases (n = 193
over the 10-year period).
To summarise, our outcome is the sum of primary first episode
hospitalizations with any of the above diagnostic codes at COA level.
Hospital admissions with the same primary diagnosis occurring within
30 days were considered as a readmission and only the first admission
was kept (n = 61,008); this is because readmissions within 30 days are
likely to represent complications from the initial condition, rather than
a new health effect resulting from re-exposure (NHS Digital, 2019).
Hospital admissions were also excluded if data on sex and age were
missing (n = 57) or if the admission date was prior to the opening date
of the closest composting facility (n = 240,188). If a facility started
operating mid-year, all admissions for that year were excluded. Fig. 2
summarises the data cleaning process. In the main analysis, hospital
admissions from people of all ages were included with the exception of
COPD and Cystic Fibrosis. The common age of onset for COPD onset is
over 65 years old, with early COPD onset occurring around 40–50 years
old (Abramson et al., 2014; Kobayashi et al., 2017). Survival for Cystic
Fibrosis patients is currently approximately 50 years (Keogh et al.,
2018). Therefore, we excluded any case of COPD and of Cystic Fibrosis
hospitalisation registered in patients aged<40 years and>50 years
old, respectively, as this is likely reflecting extreme cases or coding and
diagnostic errors.
2.5. Confounder data
Area level deprivation was captured through the Carstairs index, a
composite measure of deprivation consisting of four deprivation in-
dicators (i.e. unemployment, household overcrowding, no car owner-
ship and social class (Carstairs and Morris, 1989)). Carstairs deprivation
scores were computed using input data from the 2011 census, stan-
dardized across England at COA level and categorised into quintile
groups for the analysis.
Weekly tobacco expenditure data (pounds spent per week) for
COAs, used as a proxy for tobacco smoking, were obtained from CACI
Ltd (CACI, 2014) for 2014. Data were estimated per person aged ≥16
years using data population information from the 2011 census, re-
sulting in pounds spent per week on tobacco per person aged≥16 years
per COA. Tobacco expenditure was used as a continuous variable.
Each COA was classified as rural or urban as there may be more
natural sources of Aspergillus fumigatus and other fungi in rural settings.
Areas were classified according to the 2011 Rural-Urban Classification
provided by (ONS, 2018), which is based on population density and
accessibility.
Traffic-related air pollution such as PM2.5 and NO2, have been
shown to be positively associated with respiratory hospitalisations
(Lipfert, 2017) and could confound our results. We used annual average
daily traffic load data from 2013 (vehicles per day × m) from major
roads within 150 m of each postcode (measured as the product of traffic
intensity and the length of major road fragments within a 150 m buffer)
as a proxy for traffic-related air pollution, similarly to Lanki et al.
(2015). Major roads where defined as those with> 10,000 vehicles
based on work by Morley and Gulliver (2016). Total estimates per
postcode were aggregated to COA level as a proxy of air pollution ex-
posure from major roads.
A. Roca-Barcelo, et al. Environmental Research xxx (xxxx) xxxx
5
2.6. Statistical analysis
We examined the association between the number of respiratory-
related hospital admissions and the modelled concentration of
Aspergillus fumigatus categorised into quartiles relative to each com-
posting facility. We fitted a generalized mixed model, assuming a
Poisson distribution for the COA-level number of hospital admissions.
Expected counts were estimated using age- and sex-specific rates de-
rived from the entire study population and applied to the age- and sex-
specific population estimates of each COA, available from the Office for
National Statistics (ONS). We fitted a model with no adjustment for
area-level confounders (Model 1) and a model (Model 2) fully adjusted
for COA level: rural/urban classification, deprivation (Carstairs quin-
tiles), tobacco expenditure, and road-traffic load index. The equation
for Model 2 is provided in Appendix D Eq. (D.1.). For both models, we
included a random intercept for each composting facility to allow for
differences in baseline rates, and a nested random intercept for each
COA to account for over dispersion. Analyses were conducted sepa-
rately for each health event (i.e. all respiratory-related disease, re-
spiratory infections, asthma, COPD, and Cystic Fibrosis).
All analyses were conducted in STATA version 13 (StataCorp,
2013).
2.7. Sensitivity analyses
Several sensitivity analyses were conducted to understand potential
uncertainties introduced during the data handling (Appendix E, Table
E1 and Fig. E1.). A sensitivity analysis was conducted including facil-
ities that were in-vessel but had an outdoor composting component
(n = 94) (sensitivity analysis 1). To assess the impact of excluding
composting facilities with overlapping 4 km buffers, we conducted a
sensitivity analysis where we included them (sensitivity analysis 2). The
effect of the coverage rate of the postcodes modelled within each COA
under study, was assessed through sensitivity analysis 3 and 4 were we
applied less restrictive criteria and included any COA which had
modelled concentrations for at least 75% of its postcodes, for both open
windrow composting facilities only and for all facilities with an outdoor
composting component, respectively. We also looked at health effects
on vulnerable groups including children (aged ≤19 years old) and the
elderly (aged ≥65 years old) (sensitivity analyses 5 and 6, respec-
tively). Finally, we limited the analyses to composting facilities located
in rural and urban areas only (sensitivity analyses 7 and 8, respec-
tively).
In addition, during the data exploration, we observed some varia-
bility in the exposure distribution between meteorological stations and
composting facilities. Therefore, we explored additional models by (i)
adding an overarching random intercept for meteorological station; (ii)
adding a random slope for meteorological station, and (iii) adding a
random slope for composting facility, always holding for the hier-
archical random nested intercept structure of COA within composting
facility. However, based on the Akaike Information Criterion (AIC)
there was not enough evidence that the fit of the model improved (data
not shown). Therefore, the most parsimonious model was used (Model
2, Appendix D Eq. (D.1).
3. Results
Overall, 76 large scale open windrow composting facilities were
included in the study (Fig. 1). Postcode-level modelled estimates of
Aspergillus fumigatus concentrations were obtained and aggregated
spatially and temporally. A total of 9606 COAs with a population-
weighted centroid within 4 km of the composting facility were included
Table 1
Total and percentage of hospital admissions overall and by exposure quartiles in the study area.
Overall Exposure quartiles
Q1 - Least exposed Q2 Q3 Q4 - Most exposed
n % n % n % n % n %
Hospital admissionsa
All respiratory (ICD 10, J00-J99) 249,748 60,659 24.3 64,994 26.0 64,123 25.7 59,972 24.0
Respiratory infections only (ICD 10, J00-J22) 134,802 32,776 24.3 35,241 26.1 34,473 25.6 32,312 24.0
Asthma only (ICD 10, J45-J46) 20,927 5206 24.9 5700 27.2 5374 25.7 4647 22.2
COPD only (ICD 10, J40-J44) 35,820 8480 23.7 9470 26.4 9331 26.0 8539 23.8
Disease due to organic dust (ICD 10, J66-J67) 193 61 31.6 50 25.9 50 25.9 32 16.6
Cystic Fibrosis (ICD 10, E84) 3163 848 26.8 827 26.1 715 22.6 773 24.4
Number of hospital admissions by age group (years)b
0–19 years 74,465 29.4 18,405 29.9 19,517 29.7 18,985 29.3 17,558 28.9
20–39 years 35,215 13.9 8608 14.0 9356 14.2 9134 14.1 8117 13.4
40–64 years 39,977 15.8 9938 16.2 10,000 15.2 10,315 15.9 9724 16.0
≥65 years 103,254 40.8 24,556 39.9 26,948 40.9 26,404 40.7 25,346 41.7
Sexb
Male 129,117 51.1 31,417 51.1 33,398 50.7 33,214 51.2 31,088 51.2
Female 123,794 48.9 30,090 48.9 32,423 49.3 31,624 48.8 29,657 48.8
Carstairs deprivation quintileb,c
Q1- Least deprived 31,946 12.6 8114 13.2 6459 9.8 7191 11.1 10,182 16.8
Q2 40,553 16.0 10,066 16.4 9170 13.9 9123 14.1 12,194 20.1
Q3 45,965 18.2 10,736 17.5 12,182 18.5 11,861 18.3 11,186 18.4
Q4 56,186 22.2 11,136 18.1 14,812 22.5 16,739 25.8 13,499 22.2
Q5 - Most deprived 78,261 30.9 21,455 34.9 23,198 35.2 19,924 30.7 13,684 22.5
Number of people living inb
Rural areas 28,782 11.4 7524 12.2 5498 8.4 5673 8.7 10,087 16.6
Urban area 224,129 88.6 53,983 87.8 60,323 91.6 59,165 91.3 50,658 83.4
Mean (SD) tobacco expenditure (£ spent per week per person aged ≥16 years
per COA)b, c
7.6 (2.7) 7.5 (2.7) 7.8 (2.6) 7.7 (2.7) 7.2 (2.9)
Mean (SD) traffic load (vehicles per day per m)b,c,d 1.5 (0.7) 1.5 (0.7) 1.5 (0.7) 1.5 (0.7) 1.6 (0.8)
a – Percentages given over overall admissions (i.e. across rows).
b – Information given for all respiratory-related hospital admissions.
c – At COA level.
d – Traffic load as proxy for traffic air pollution within 150 m
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in the analyses, after excluding COAs with incomplete coverage of
modelled postcodes (Appendix E, Table E1.). Results from the disper-
sion modelling have been described elsewhere (Williams et al., 2019).
There was a total of 249,748 primary non-repeat first-episode re-
spiratory-related hospital admissions over the study period and 3163
Cystic Fibrosis hospital admissions (Table 1, Fig. 2). Population char-
acteristics of the hospital admissions included in the main analyses,
overall and per exposure quartile, are provided in Table 1.
The most common causes of hospitalisation were respiratory in-
fections (n = 134,802) followed by COPD (n = 35,820) and asthma
(n = 20,927) (Table 1, Fig. 2). There were no noteworthy differences in
the occurrence of both overall and disease-specific hospitalisations
across exposure quartiles except for disease due to organic dust which
showed a lower occurrence in the most exposed quartile (16.6%)
(Table 1). The most common ages for hospitalisation was ≥65 years
(40.8%), followed by≤ 19 years (29.4%) with similar age distribution
within each exposure quartile. There were slightly more males hospi-
talised overall (51.1%) and across exposure quartiles. Hospitalisations
were mainly from persons living in deprived areas (i.e. Carstairs quin-
tile 4 and 5) always representing more than 50% of all hospitalisations,
both overall and by exposure quartiles. Most of the hospital admissions
occurred in urban areas (88.6%, Table 1) where most of the population
reside (87.2%, Appendix F). The mean (SD) weekly expenditure in to-
bacco among population aged≥16 years old was 7.6 (2.7), with similar
values across exposure quartiles. Likewise, mean (SD) traffic load
showed similar values across exposure groups to those found for the
overall study population (1.5 (0.7)). Descriptive statistics of the general
population living in the study area are provided in Appendix F Table F1.
Table 2 shows the results for the association between disease-spe-
cific hospital admissions and quartiles of exposure. The results from the
basic adjusted model (Model 1) showed a slight protective effect across
all health outcomes in areas with the highest concentrations of Asper-
gillus fumigatus. However, after models were fully adjusted (Model 2),
this effect was noticeably reduced and lost statistical significance. Of
the adjustment variables, area level deprivation quintiles and rural
classification were those explaining most of the variability (data not
shown). For all respiratory diseases and respiratory infections, we ob-
served a non-significant relative risk (RR) of 0.99 (95%CI: 0.96–1.01)
and 0.98 (95%CI: 0.95–1.00), respectively, for COAs in the highest
compared to the lowest quartile of exposure. For COPD the protective
effect disappeared completely, yet after adjustment the association re-
mained non-significant (RR = 1.01 (95%CI: 0.96–1.08). For asthma,
the magnitude of the protective effect for the highest exposed areas was
reduced and became statistically non-significant (RR = 0.97
(95%CI = 0.91; 1.04)).
Similar results were observed across all sensitivity analyses
(Appendix G).
4. Discussion
This is the first study that has examined associations between
modelled Aspergillus fumigatus concentrations and respiratory-related
hospital admissions, using a small area ecological study design. We did
not find any significant associations, neither overall nor in sub-analysis
focusing on specific respiratory subgroups such as asthma.
4.1. Comparison with other studies
In our previous study assessing the risk of hospitalisation for re-
spiratory-related health outcomes in relation to proximity to large scale
composting facilities (as a proxy for bioaerosol exposure) (Douglas
et al., 2016), we found a small non-statistically significant association
with total respiratory admissions when using a continuous measure of
distance in those living within 2.5 km of a facility. Here, using a more
sophisticated exposure measure (which accounts for important factors
influencing bioaerosol dispersion patterns, e.g. meteorological
conditions, emission characteristics) and extending our study area to
4 km, we found no statistically significant effects.
Only six other community health studies have been conducted to
date (Aatamila et al., 2011; Browne et al., 2001; Douglas et al., 2016;
Herr et al. 2003a, 2003b; Kramer et al., 1989; Liu et al., 2011), and
provide mixed evidence as to whether bioaerosol exposure from com-
posting facilities results in increased respiratory-related symptoms and
disease. Some studies showed significant increased risks of respiratory
symptoms (e.g. cough with phlegm, wheeze etc.) (Aatamila et al., 2011;
Herr et al., 2003b) or somatic complaints (Aatamila et al., 2011; Herr
et al. 2003a, 2003b), and one suggested induced pro-inflammatory
responses (Liu et al., 2011). However, two studies found no significant
associations with respiratory symptoms and disease (Browne et al.,
2001; Kramer et al., 1989). The majority of these studies relied on self-
reported health data; were conducted over short timescales; relied on
simple proxies of exposure measure (e.g. exposed vs non exposed or
proximity to composting facility), and concerned a small number of
facilities or small areas, and therefore are prone to bias (Pearson et al.,
2015).
Table 2
Relative risk (95% confidence intervals) of hospital admission for any re-
spiratory-related disease, asthma, COPD, cystic fibrosis and respiratory infec-
tions associated with quartiles of modelled concentrations of Aspergillus fu-
migatus.
Model 1a Model 2b,c
RR 95%CI p-value RR 95%CI p-value
Any respiratory related disease (ICD-10, J00-J99)
Q1 - Least
exposed
1 1
Q2 1.00 (0.98,1.03) 0.81 0.99 (0.97,1.01) 0.35
Q3 1.02 (0.99,1.04) 0.22 1.00 (0.98,1.02) 0.95
Q4 - Most
exposed
0.94 (0.92,0.97) <0.005 0.99 (0.96,1.01) 0.21
Asthma (ICD-10, J45-J46)
Q1 - Least
exposed
1
Q2 1.04 (0.97,1.11) 0.27 1.01 (0.95,1.08) 0.67
Q3 1.02 (0.96,1.09) 0.50 1.00 (0.94,1.07) 0.88
Q4 - Most
exposed
0.91 (0.85,0.97) <0.005 0.97 (0.91,1.04) 0.42
COPD (ICD-10, J40-J44)
Q1 - Least
exposed
1
Q2 1.04 (0.97,1.12) 0.27 1.00 (0.94,1.06) 0.95
Q3 1.04 (0.97,1.12) 0.22 1.01 (0.95,1.07) 0.85
Q4 - Most
exposed
0.91 (0.85,0.98) 0.01 1.01 (0.96,1.08) 0.65
Respiratory infections (ICD-10, J00-J22)
Q1 - Least
exposed
1 1
Q2 1.00 (0.97,1.02) 0.84 0.98 (0.96,1.01) 0.17
Q3 1.01 (0.98,1.04) 0.59 0.99 (0.97,1.02) 0.57
Q4 - Most
exposed
0.94 (0.92,0.97) <0.005 0.98 (0.95,1.00) 0.07
Cystic Fibrosis (ICD-10, E84)
Q1 - Least
exposed
1 1
Q2 1.11 (0.62,1.98) 0.72 1.10 (0.62,1.96) 0.74
Q3 0.93 (0.51,1.68) 0.81 0.92 (0.51,1.67) 0.78
Q4 - Most
exposed
1.03 (0.57,1.87) 0.92 1.01 (0.56,1.83) 0.98
a Model 1, Model with random intercept composting facility || random in-
tercept COA.
b Model 2, fully-adjusted model including Carstairs deprivation quin-
tile + rural/urban + tobacco sales + index for proximity to major
road + random intercept composting facility || random intercept COA.
c Not all confounders were available for all COAs (n = 2) and thus, were
excluded from Model 2.
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4.2. Exposure assessment
Strengths of the study are its national scale and use of modelled
exposure to improve on use of distance as a proxy for exposure.
Although model inputs were based on the latest evidence from the
Aspergillus fumigatusmodelling literature (Douglas et al., 2017; Williams
et al., 2019), we did not directly measure bioaerosols. Due to limita-
tions in the dispersion modelling approach, the estimated concentra-
tions could not be considered as a quantitative estimate of Aspergillus
fumigatus exposure, but could be used to provide a qualitative estimate
(as previously described (Williams et al., 2019)). Therefore, we con-
sidered that the estimated concentrations were not appropriate to
conduct a time-series study of daily predicted concentrations of Asper-
gillus fumigatus. Instead, we averaged the modelled outputs to produce a
relative indicator of bioaerosol exposure gradient. It is likely that there
will be peaks and troughs in Aspergillus fumigatus exposure, which may
impact on any health response. We were also unable to account for
natural variation in bioaerosol concentrations; there is currently limited
knowledge on background bioaerosol variation temporally and spa-
tially, particularly at genera/species level (Pearson et al., 2015;
Robertson et al., 2019). However, we were able to somewhat account
for background levels of air pollution, by using a road-traffic load index.
We also, included a random intercept in our statistical model which
allowed us to account for differences in baseline rates between com-
posting facilities.
Despite the above limitations, this is an improvement to other
commonly used bioaerosol exposure measures such as distance
(Douglas et al., 2016). We were able to investigate this by comparing
the spatial distribution of distance, wind-weighted distance and the
average modelled concentrations of Aspergillus fumigatus (Appendix H,
Section H.1.). Modelled concentrations of Aspergillus fumigatus showed a
less patched and more complex spatial distribution. This was highly
influenced by meteorology, which is consistent with previous evidence
on the influence of these factors in bioaerosol dispersion. In addition,
we tested the consistency of our results against the use of distance and
wind-weighted distance (Appendix H, Section H.2 and H.3, respec-
tively). Results using distance as a proxy showed some protective ef-
fects, particularly for asthma and COPD. When using wind-weighted
distance, which adds an additional layer of complexity to the exposure
assessment by accounting for wind direction, the effects were diluted.
This reduction was even more obvious when using modelled con-
centrations of Aspergillus fumigatus. This suggests that our exposure
assessment method is capturing some exposure dispersion patterns not
fully described by these simpler proxies, adding to the body of literature
highlighting the limitations of using distance proxies for epidemiolo-
gical studies (Hodgson et al., 2007).
We focused on Aspergillus fumigatus, a pathogenic, well-studied
bioaerosol component, which is known to be emitted from composting
facilities in elevated concentrations (Pearson et al., 2015) as a proxy for
bioaerosols more generally. Aspergillus fumigatus has been used as a
proxy for bioaerosols in previous studies (Douglas et al., 2017), but this
field would benefit from more research looking at the validity of using
Aspergillus fumigatus as a proxy to describe spatial patterns of bioaerosol
dispersion and more importantly, exploring multi-component exposure
measures to better capture bioaerosol dispersion properties.
4.3. Health outcome data
We used objectively collected hospital admissions data, an im-
provement on subjective self-reported questionnaire data which has
been frequently used in previous community health studies (Pearson
et al., 2015). It was difficult to fully evaluate the impacts of Aspergillus
fumigatus exposure on Cystic Fibrosis sufferers due to small numbers.
We may have underestimated true effects, due to our inclusion criteria.
If a composting facility started operating mid-year, we did not consider
any hospital admissions for the entire calendar year. This would have
resulted in the possible exclusion of cases immediately after the facility
began operation, when emissions may be higher or more variable as the
facility establishes its management processes and best-practises. In
addition, by using hospitalisation data we are only capturing severe
health outcomes and thus, milder health effects are not being con-
templated here (probably dealt with at a primary health care or
emergency department unit or at home if minor). We used the NHS
standard definition of readmission being within 30 days or index ad-
mission. However, this may vary by disease.
4.4. Results interpretation
Hospital admissions represent more severe respiratory episodes.
Therefore, our results showing no significant associations between
modelled Aspergillus fumigatus exposure and respiratory-related hospi-
talisation suggest that bioaerosols are unlikely to have a severe impact
on respiratory disease. However, given the limitations in the dispersion
modelling, risks cannot be completely ruled out. We cannot rule out an
impact on less severe symptoms managed without admission to hospital
(e.g. home managed, as outpatients, or with General Practitioners
(GPs)). Patients with existing chronic diseases are also more likely to be
closely monitored and thus, complications of their health status may be
detected and addressed at early stages, avoiding severe complications
and thus, hospitalisation.
We cannot rule out residual confounding. Additionally, people
living in most exposed areas may take medication in response to mild
symptoms triggered by the exposure itself which would avoid their
condition to worsen and thus, lead to hospitalisation (Silverwood et al.,
2018). Also, it has been suggested that sustained exposure to bioaerosol
emissions over time may act as a selection pressure to improve the
immune system (i.e. the biodiversity hypothesis (von Hertzen et al.,
2011), an extension of the hygiene hypothesis (Strachan, 1989)). Our
results could potentially reflect the establishment of an immune toler-
ance to bioaerosols in higher exposed areas.
This study is a cross-sectional ecological study, and thus, results
apply to areas and not individuals, and do not inform on longer-term
trends of disease. We were unable to account for migration in and out of
areas, individual-level factors (such as personal exposure, medical his-
tory, presence of indoor mould, building quality and insulation, etc.) or
investigate seasonal patterns.
4.5. Future considerations
Future studies should consider individual-level exposure and health
outcomes over longer time periods, making use of emerging work im-
proving on measurement and modelling of bioaerosols emissions from
composting facilities. Multiple health-effects should be explored, using
objective health measurements (e.g. lung function, inflammatory mar-
kers, changes in the respiratory microbiome), alongside subjective
symptom diaries and questionnaires. It is essential for these measure-
ments to be conducted longitudinally at regular intervals (ideally in
real-time), to capture peaks and troughs in exposure and subsequent
health impacts. Indoor bioaerosol exposure should also not be ignored,
as outdoor bioaerosols may enter and colonise nearby buildings, which
is not currently well understood. Moreover, indoor exposure may be an
important confounder, as people working or living in damp buildings
are more likely to be exposed to fungi, which can cause several re-
spiratory conditions (European Lung Foundation. Mould, 2017).
5. Conclusions
We conducted a national small-area cross sectional study of health
effects of estimated Aspergillus fumigatus emissions from large scale
composting facilities. Results did not show any increased risk of all
types of respiratory-related conditions together, respiratory infections,
asthma, COPD, or Cystic Fibrosis hospital admissions in areas with
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higher exposure of Aspergillus fumigatus. This suggests that large scale
composting facilities do not influence severe respiratory disease pre-
valence in surrounding communities. However, this needs confirma-
tion, ideally with time-resolved exposure estimates to explore whether
daily or weekly spikes in exposure are associated with health impacts.
Given the study design, we also cannot comment on potential effects on
less severe respiratory disease or symptoms suggested in some previous
research, nor on potential for short-term impacts of intermittent high
bioaerosol emissions.
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